Authors
Latest:
Outside-In: Why Putting Patients at the Heart of Drug Development MattersThis article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.
Latest:
Outside-In: Why Putting Patients at the Heart of Drug Development MattersThis article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.
Latest:
Trends in Global Public and Patient Perceptions of Clinical ResearchTo inform our understanding of public and patient trust and confidence, this article provides a high-level summary of the results of two studies monitoring trends in international public and patient attitudes and perceptions.
Latest:
Signal Management in Excel is Stifling Pharmacovigilance InnovationDo users actually want to use Excel? Explore the different viewpoints behind choosing SaaS or Excel.
Latest:
Back to Basics? Physician Awareness and Nucleic Acid-Based TherapiesSurvey data finds that physicians aren’t very familiar with the intricacies of nucleic acid-based therapies.
Latest:
User Experience (UX) to Help Participants Find Trials on the WebHealthcare professionals are engaged in an increasingly competitive fight to attract and retain clinical trial participants through the use of user experience (UX).
Latest:
The Transformation of Clinical Trials from Writing on Papyrus to the World of TechnologyNew requirements must be put in place to ensure data quality and integrity.
Latest:
Closer Pharma-Diagnostic Collaboration is Key to Alzheimer’s Drug R&DPharma and diagnostics companies need to strengthen alignment in Alzheimer’s disease research-to help turn science and data into actionable medical innovations.
Latest:
Cancer Trials: Raising Accrual RatesLessons learned from the recruitment of colorectal cander patients into clinical trials.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
De-Risking Trials with Science-Driven OversightIdentifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring: Barriers to AdoptionExamining the barriers, challenges, and outcomes to determine the effectiveness of different RBM implementation approaches.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Cold Chain as a ServiceAccording to the IQVIA Institute for Human Data Science, the pharmaceutical industry loses roughly $35 billion annually as a result of temperature excursions, making transport one of the weakest links in many manufacturers’ supply chains.
Latest:
Multiple Expansion Cohort Clinical Trials: A Shorter Path to Success for Oncology DrugsThe rapid rise of targeted drugs and biologics in oncology has spurred sponsors and the FDA to innovate, leading to the creation of a variation to the typical trial design that can include multiple expansion cohorts.
Latest:
Want to Ensure Trial Success? Effective Management of Internal Team Calls may be a KeyIt is important to devote quality time to challenge yourself and your teams on whether there is a need to strategize and rethink the way you are conducting teleconferences for your clinical trials.
Latest:
The Ghost of Clinical Trials Past, Present, and FutureHave you seen many paradigm shifts lately?
Latest:
Data Dilemmas in Clinical Trials ContinueSurvey uncovers key findings amid today’s explosion of data volume and sources-and the added complexity in managing clinical data.
Latest:
Using Facebook Ads to Recruit Clinical Study ParticipantsFirst column in this series looks at the effectiveness of digital marketing as an outreach tool.
Latest:
Q&A: Capitalizing on Technology-Enabled Clinical ResearchIn the following Q&A, Guillaume Marquis-Gravel, MD, and Kevin Monroe discuss the advancements and related challenges of incorporating new technological tools in drug development, including eClinical approaches currently undertaken in the foundation’s own studies.
Latest:
Q&A: Capitalizing on Technology-Enabled Clinical ResearchIn the following Q&A, Guillaume Marquis-Gravel, MD, and Kevin Monroe discuss the advancements and related challenges of incorporating new technological tools in drug development, including eClinical approaches currently undertaken in the foundation’s own studies.
Latest:
How Tech and Data Enable Patient-Centric Clinical TrialsRemote trials have the potential to increase recruitment, reduce attrition, and make patients feel more engaged with the research.
Latest:
Non-Data Scientists: The Evolving Role of Clinical Data ManagementThe “citizen data scientist” is the person with no official data scientist training who uses the latest tools and technologies to handle data wrangling duties, analyze data, and create reports and models.
Latest:
Can Data from EHR Systems Be Trusted in a Trial Setting?An increase in use of EHR systems at clinical investigative sites adds more expectations for clinical trial sponsors to comply by regulatory requirements.
Latest:
Can Data from EHR Systems Be Trusted in a Trial Setting?An increase in use of EHR systems at clinical investigative sites adds more expectations for clinical trial sponsors to comply by regulatory requirements.
Latest:
Can Data from EHR Systems Be Trusted in a Trial Setting?An increase in use of EHR systems at clinical investigative sites adds more expectations for clinical trial sponsors to comply by regulatory requirements.
Latest:
Can Data from EHR Systems Be Trusted in a Trial Setting?An increase in use of EHR systems at clinical investigative sites adds more expectations for clinical trial sponsors to comply by regulatory requirements.
